Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Current Assets (2016 - 2017)

Tenax Therapeutics' Current Assets history spans 5 years, with the latest figure at $8.7 million for Q3 2017.

  • For Q3 2017, Current Assets rose 12.99% year-over-year to $8.7 million; the TTM value through Sep 2017 reached $8.7 million, up 12.99%, while the annual FY2016 figure was $13.6 million, N/A changed from the prior year.
  • Current Assets for Q3 2017 was $8.7 million at Tenax Therapeutics, down from $9.0 million in the prior quarter.
  • Across five years, Current Assets topped out at $20.6 million in Q4 2015 and bottomed at $7.7 million in Q3 2016.
  • The 3-year median for Current Assets is $10.2 million (2016), against an average of $11.8 million.
  • The largest annual shift saw Current Assets plummeted 33.72% in 2016 before it increased 12.99% in 2017.
  • A 3-year view of Current Assets shows it stood at $20.6 million in 2015, then tumbled by 33.72% to $13.6 million in 2016, then plummeted by 36.43% to $8.7 million in 2017.
  • Per Business Quant, the three most recent readings for TENX's Current Assets are $8.7 million (Q3 2017), $9.0 million (Q2 2017), and $12.8 million (Q1 2017).